Blackstone Life Sciences announces $4.6bn fundraise

The $4.6 billion final close of Blackstone Life Sciences V was not only oversubscribed -- it was also the largest life sciences private fund to be raised to date, according to Blackstone officials.

The firm said it has already invested and committed nearly $1 billion from the fund over the past three months, including deals with Alnylam, Reata Pharmaceuticals and Continue Reading With Our Special Offer

Unlock this article instantly, along with the rest of our premium content and newsletters, with a 20% discount by using the coupon code VIDRIO2021.

Get this deal

Already a subscriber? Log in.

Related Articles

Back to top button